Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 20.56
Key Takeaways
Risk factor
Sufficiently resilient to price shocks
Data is available to registered users only
Data is available to registered users only
Profitability factor
Decent price performance
Data is available to registered users only
Data is available to registered users only
About
Tibet AIM Pharm. Inc. engages in the research and development of medical products in China. The company's products include Miglitol tablets for diabetes; Gualoupi injection for coronary disease; Oxytocin injection for gynecology and obstetrics; NalMefene injection for various acute poisoning, such as alcohol, organic phosphor, CO, sedative-hypnotic, opioid substance, serious infection, shock, fainting, and brain;...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive' on
Data is available to registered users only
Buy
Sell